UDBEST-450 ER
MRP: 5,800
Packaging: 10x10
Pack Type: tablet
Composition:
Ursodeoxycholic Acid 450mg (ER)
Indication:
Primary Biliary Cholangitis, Dissolving Of Cholesterol Stones
Description:
UrsoCure XR 450 contains Ursodeoxycholic Acid (UDCA) 450 mg in an Extended-Release (ER) formulation, designed for once-daily dosing. It provides sustained action in improving bile flow, protecting liver cells, and dissolving cholesterol gallstones. This high-strength, prolonged-release format ensures steady plasma levels, improving patient compliance and therapeutic outcomes.
Tags:
- Once-daily dosing for better patient adherence
- Dissolves non-calcified cholesterol gallstones
- Reduces liver enzyme levels (ALT, AST, ALP)
- Protects liver cells in chronic liver diseases
- Improves bile secretion and reduces toxicity
Usage Information
Dosage
Usual Adult Dose: One tablet (450 mg) once daily, preferably with food Dose may be increased as per physician’s advice (up to 900 mg/day) Long-term use may be required in chronic liver disorders Do not chew or crush ER tablets
Side Effects
Mild gastrointestinal upset (diarrhea, nausea) Rash or allergic reaction (rare) Temporary rise in liver enzymes (self-limiting)
Contraindications
Hypersensitivity to UDCA Complete biliary obstruction Radiopaque or calcified gallstones Severe hepatic or renal dysfunction Use with caution in pregnancy & lactation
Availability
Ursodeoxycholic Acid 450 mg ER UDCA extended-release tablet Gallstone dissolving once-daily medicine Liver detox supplement UDCA PBC treatment with extended-release UDCA UDCA 450mg for fatty liver